Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome

World Journal of Gastroenterology

Volumn 11, Issue 30, 2005, Pages 4715-4720

  Lo, Ching Chu ^a   Hsu, Ping I ^a   Lo, Gin Ho ^a   Lai, Kwok Hung ^a   Tseng, Hui Hwa ^a   Lin, Chiun Ku ^a   Chan, Hoi Hung ^a   Tsai, Wei Lun ^a   Chen, Wen Chi ^a   Peng, Nan Jing ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anti Helicobacter pylori antibodies; Anti parietal cell antibody; Gastric cancer; Glandular atrophy; Intestinal metaplasia

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; PARIETAL CELL ANTIBODY; UREASE;

ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM ULCER; EARLY DIAGNOSIS; ENZYME ANALYSIS; FEMALE; FREQUENCY ANALYSIS; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PREVALENCE; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH ULCER;

EID: 23844540147     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i30.4715     Document Type: Article

References (23)

1. American Cancer Society. Statistics for 2001. Available at: http://www.cancer.org/eprise/main/docroot/STT/stt_02001. Accessed March 21, 2002
2. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387-400
3. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans. Schistosomes, Liver flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer 1994: 177-240
4. Dooley CP, Fitzgibbons PL, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histological gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562-1566
5. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, Applemelk BJ, Scheuk BE, Meuwissen SG. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol 1997; 223: 28-34
6. Ellis DJ, Speirs C, Kingston RD, Brookes VS, Leonard J, Dykes PW. Carcinoembryonic antigen levels in advanced gastric carcinoma. Cancer 1978; 42: 623-625
7. Nomura AHY, Stemmermann GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980; 93: 537-540
8. McGuigan JE, Trudeau WKL. Serum and tissue gastrin concentration in patients with carcinoma of stomach. Gastroenterology 1973; 64: 22-25
9. Ito M, Haruma K, Kaya S, Kamada T, Kim S, Sasaki A, Sumii M, Tanaka S, Yoshihara M, Chayama K. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis. Scand J Gastroenterol 2002; 37: 287-293
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis. Am J Surg Pathol 1996; 20: 1161-1181
11. Hsu PI, Lai KH, Tseng HH, Lo GH, Lo CC, Lin CK, Cheng JS, Chan HH, Ku MK, Peng NJ, Chien EJ, Chen W, Hsu PN. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 195-201
12. Hsu PI, Lai KH, Tseng HH, Lin CK, Lo GH, Cheng JS, Chan HH, Chen GC, Jou HS, Peng NJ, Ger LP, Chen W, Hsu PJ. Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases. J Clin Gastroenterol 2000; 30: 386-391
13. Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC, Tseng HH, Huang WK, Lo GH, Hsu PI. Endoscopic 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Dig Liver Dis 2003; 35: 73-77
14. Hsu PI, Lai KH, Tseng HH, Lin YC, Yen MY, Lin CK, Lo GH, Huang RL, Cheng JS, Huang WK, Ger LP, Chen W, Hsu PN. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol 1997; 25: 587-591
15. Kuipers EJ, Uyterlinde AM, Pena AS, Poosendaal R, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-1528
16. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131
17. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-1739
18. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: An endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16-20
19. Yoshimura T, Shimoyama T, Fukuda S, Tanaka M, Axon ATR, Munakata A. Most gastric cancer occurs on the distal side of the endoscopic atrophic border. Scand J Gastroenterol 1999; 34: 1077-1081
20. Stolte M, Meining A. Helicobacter pylori gastritis of the gastric carcinoma phenotype: Is histology capable of identifying high-risk gastritis? J Gastroenterol 2000; 35(Suppl 12): 98-101
21. Strickland RG, Machay A. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 18: 426-440
22. Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, Kohli Y. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994; 343: 542-543
23. Kukao A, Komatsu S, Tsubono Y, Hisamichi S, Ohori H, Ohsato N, Fujino N, Endo N, Iha M. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors-a cross-sectional study. Cancer Causes Control 1993; 4: 307-312